Fortress Biotech, Inc.

FBIOP

$64M

Micro Cap

NASDAQBiotechnology🇺🇸North America101 employees

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Feb 9, 2026

Tomorrow

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply

Market Overview

Stock performance and market intelligence

Catalyst Timeline

2 upcoming, 0 past

🎯PDUFANext

FDA PDUFA Date CUTX-101 (standard)

2/9/2026

For Wilson's disease. NDA filing. Extracted from SEC filing: 8-K

Source

🎯PDUFA

FDA PDUFA Date IV Tramadol (standard)

8/26/2026

NDA filing. Extracted from SEC filing: 8-K

Source

AI Predictions & Institutional Flow

Machine learning insights and smart money movement

FDA Submissions

Pending NDA/BLA submissions with predicted PDUFA dates

Drug Pipeline

Clinical development programs and drug candidates

Drug Pipeline

No drugs found in this phase.

Regulatory & News

Approvals, filings, and latest developments

Regulatory Approvals

FBIOP News